Stable over-expression of estrogen receptor-α in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor

Molecular and Cellular Endocrinology

Volumn 152, Issue 1-2, 1999, Pages 1-9

  Hamid Ali, Syed ^a   O'Donnell, Amy L ^b,c   Mohamed, Seema ^d   Mousa, Shakir ^d   Dandona, Paresh ^a  

^a Diabetes Endocrinology Center of Western New York   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d DUPONT COMPANY   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; ECV304; Endothelial cells; Endothelin 1; Estrogen; Estrogen receptor ; Growth behavior; Heart disease; Proliferation rate; Stable transfection; Vascular disease

Indexed keywords

ENDOTHELIN 1; ESTROGEN RECEPTOR; VASCULOTROPIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; GROWTH RATE; GROWTH STIMULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; WESTERN BLOTTING;

ARTERIOSCLEROSIS; CELL DIVISION; CELL LINE; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; HUMANS; LYMPHOKINES; RECEPTORS, ESTROGEN; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033603478     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00065-9     Document Type: Article

References (55)

1. Abdel-Rahman, E., Harris, L., Mangione, S.A., Ricotta, J.R., Dandona, P., 1995.The expression of estrogen receptor by rabbit aortic endothelial cells and their modulation by estrogen (abstract). Program of The Endocrine Society 77th Annual Meeting, Washington, DC, USA pp. 221.
2. Abdel-Rahman, E., Harris, L., Huribal, M., Mangione, S.A., Ricotta, J.R., Dandona, P., 1996a. Estrogen deficiency (oophorectomy) causes increased endothelial endothelin and intercellular adhesion molecule-1 (ICAM-1) levels (abstract). Program of The 10th International Congress of Endocrinology Meeting, San Francisco, CA, USA, pp. 196.
3. Abdel-Rahman, E., Harris, L., Stiles, J., et al., 1996b. Estrogen deficiency induces endothelial cell mitogenicity (abstract). Program of The 10th International Congress of Endocrinology Meeting, San Francisco, CA, USA, pp. 196.
4. Aitken S.C., Lippman M.E. Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture. Cancer Res. 42:1982;1727-1735.
5. Akishita M., Ouchi Y., Miyoshi H. et al. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis. 125(1):1996;27-38.
6. Best P.J., Berger P.B., Miller V.M., Lemman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann. Intern. Med. 128(4):1998;285-288.
7. Cavailles V., Augereau P., Garcia M., Rochefort H. Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acid Res. 16:1988;1903-1919.
8. Dees C., Foster J.S., Ahamed S., Wimalasena J. Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ. Health Perspect. 105(Suppl. 3):1997;633-636.
9. Dubik D., Dembinski T., Shiu R. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res. 47:1987;6517-6521.
10. Farhat M.Y., Vargas R., Dingaan B., Ramwell P.W. In vivo effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of endothelium. Br. J. Pharmacol. 107:1992;679-683.
11. Fischer-Dzoga K., Wissler R., Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue cells induced by hyperlypemic serum. Exp. Mol. Pathol. 39:1983;355.
12. Furlow J.D., Murdoch F.E., Gorski J. High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J. Biol. Chem. 268(17):1993;12519-12525.
13. Gill G., Ptashne M. Negative effect of the transcriptional activator GAL4. Nature. 334:1988;721-724.
14. Greb R.R., Heikinheimo O., Williams R.F., Hodgen G.D., Goodman A.L. Vascular endothelial growth factor in primate endometrium is regulated by estrogen-receptor and progesterone-receptor ligands in vivo. Hum. Reprod. 12(6):1997;1280-1292.
15. Greene G.L., Nolan C., Engler J.P., Jensen E.V. Monoclonal antibodies to human estrogen receptor. Proc. Natl. Acad. Sci. USA. 77:1980;5115-5119.
16. Horwitz K.B., McGuire W.L. Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem. 253:1978;8185-8191.
17. Hughes S.E. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp. Cell. Res. 225(1):1996;171-185.
18. Hunley T.E., Iwasaki S., Homma T., Kon V. Nitric oxide and endothelin in pathophysiological settings. Pediatr. Nephrol. 9:1995;235-244.
19. Huo B., Dossing D.A., Dimuzio M.T. Generation and Characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene. J. Bone Mineral Res. 10(5):1995;769-781.
20. Hyder S.M., Stancel G.M., Chiappetta C., Murthy L., Boettger-Tong H.L., Makela S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res. 56(17):1996;3954-3960.
21. Janne O.A. Androgen interaction through multiple steroid receptors. NIDA Res. Monogr. 102:1990;178-186.
22. Karas R.H., Baur W., Tassi L., Mendelsohn M.E. Inhibition of vascular smooth muscle cell proliferation by estrogen. Circulation. 88:1993;325.
23. Kuiper G.G.J.M., Gustafsson J.-A. The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogen and anti-estrogen. FEBS Lett. 410:1997;87-90.
24. Kushner P.J., Hort E., Shine J., Baxter J.D., Greene G.L. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol. Endocrinol. 4(10):1990;1465-1473.
25. Lau C.K., Subramaniam M., Rasmussin K., Spelsberg T.C. Rapid inhibition of the c-jun proto-oncogene expression in avian oviduct by estrogen. Endocrinology. 127(5):1990;2595-2597.
26. Levenson A.S., Jordan V.C. Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J. Steroid Biochem. Mol. Biol. 51(5/6):1994;229-239.
27. Lundholt B.K., Madsen M.W., Lykkesfeldt A.E., Petersen O.W., Briand P. Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA. Mol. Cell. Endocrinol. 119:1995;47-59.
28. Maminta M.L.D., Molteni A., Rosen S.T. Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression. Mol. Cell. Endocrinol. 78:1991;61-69.
29. Matsura A., Yamochi W., Hirata K., Kawashima S., Yokoyama M. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. Hypertension. 32(1):1998;89-95.
30. May F.E.B., Westley B.R. Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 262:1987;15894-15899.
31. May F.E.B., Johnson M.D., Wiseman L.R., Wakeling A.E., Kastner P., Westley B.R. Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. J. Ster. Biochem. 33:1989;1035-1041.
32. McDonnell D.P., Nawaz Z., O'Malley B.W. In situ distinction between steroid receptor binding and transactivation at a target gene. Mol. Cell. Biol. 11:1991;4350-4355.
33. Mendelsohn M.E., Karas R.H. Estrogen and the blood vessel wall. Curr. Opin. Cardiol. 9:1994;619-626.
34. Metzger D., Berry M., Ali S., Chambon P. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol. Endocrinol. 9(5):1995;578-579.
35. Meyer M., Gronemeyer H., Turcotte B., Bocquel M., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell. 57:1989;433-442.
36. Morey A.K., Pedram A., Razandi M. et al. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology. 138(8):1997;3330-3339.
37. Morey A.K., Razandi M., Pedram A., Hu R.-M., Prins B.A., Levin E.R. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem. J. 330:1998;1097-1105.
38. Murphy L.J., Murphy L.C., Friesen H.G. Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology. 120:1987;1882-1888.
39. Neuman E., Ladha M.H., Lin N. et al. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17(9):1997;5338-5347.
40. Paech K., Webb P., Kuiper G.G.J.M. et al. Differential ligand activation of estrogen receptors ER-α and ER-β at API sites. Science. 277:1997;1508-1510.
41. Peiro C., Redondo J., Rodriguez-Martinez M.A. et al. Influence of endothelium on cultured vascular smooth muscle cell proliferation. Hypertension. 25(4 Pt 2):1995;748-751.
42. Pennisi E. Differing roles found for estrogen's two receptors. Science. 277:1997;1439.
43. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning, second ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
44. Takahashi K., Sawasaki Y., Hata J., Mukai K., Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell. Dev. Biol. 26(3 Pt 1):1990;265-274.
45. Travers M.T., Knowler J.T. Oestrogen-induced expression of oncogenes in the immature rat uterus. FEBS Lett. 211:1987;27-30.
46. Trowbrige J.M., Rogatsky I., Garabedian M.J. Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Proc. Natl. Acad. Sci. USA. 94(19):1997;10132-10137.
47. Usala S.J., Tennyson G.E., Bale A.E. et al. A base mutation of the c-erbAβ thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. J. Clin. Invest. 85:1990;93-100.
48. Vargas R., Wroblewska B., Rego A., Hatch J., Ramwell P.W. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br. J. Pharmacol. 109:1993;612-617.
49. Watts C.K., Sweeney K.J., Warlters A., Musgrove E.A., Sutherland R.L. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Can. Res. Treat. 31(1):1996;95-105.
50. Webb P., Lopez G.N., Greene G.L., Baxter J.D., Kushner P.J. The limit of the cellular capacity to mediate an estrogen response. Mol. Endocrinol. 6(2):1992;157-167.
51. Weisz A., Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol. 2:1988;816-824.
52. Wilding G., Lippman M.E., Gelman E.P. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res. 48:1988;802-805.
53. Zava D.T., McGuire W.L. Human breast cancer: androgen action mediated by estrogen receptor. Science. 199:1978a;787-788.
54. Zava D.T., McGuire W.L. Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology. 100:1978b;624-631.
55. Ziche M., Morbidelli L., Donnini S., Ledda F. ETB receptors promote proliferation and migration of endothelial cells. J. Cardiovasc. Pharm. 26(Suppl. 3):1995;S284-S286.